Answers are grounded in this paper and cite their sources.
Ro 13-9904/001 is a novel parenteral cephalosporin antibiotic with potent in vitro activity against a wide range of beta-lactamase-producing and non-producing pathogens. In addition, Ro 13-9904/001 proved to possess a very long plasma half-life and, as a consequence, high prophylactic in vivo effectiveness.
No takes yet. Share an insight, caveat, or question.
Reiner et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: